Evidence map›Paper›PMID 34234526›Full record

ReviewInternational journal of general medicine2021

Epidemiology and Outcomes of Status Epilepticus.

Michele Ascoli, Edoardo Ferlazzo, Sara Gasparini, Giovanni Mastroianni, Rita Citraro, Roberta Roberti, Emilio Russo

Abstract readReview
In one paragraph

Review in International journal of general medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pathophysiology of Status Epilepticus Revisited.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michele AscoliDepartment of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy.
Edoardo FerlazzoDepartment of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy.
Sara GaspariniDepartment of Medical and Surgical Sciences, Magna Græcia University, Catanzaro, Italy.
Giovanni MastroianniRegional Epilepsy Centre, Great Metropolitan Hospital, Reggio, Calabria, Italy.
Rita CitraroScience of Health Department, Magna Græcia University, Catanzaro, Italy.
Roberta RobertiScience of Health Department, Magna Græcia University, Catanzaro, Italy.
Emilio RussoScience of Health Department, Magna Græcia University, Catanzaro, Italy.ORCID 0000-0002-1279-8123

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Status epilepticus (SE) is a neurological and medical emergency, defined as a condition resulting either from the failure of the mechanisms responsible of seizure self-limitation or from the initiation of mechanisms which lead to atypically prolonged seizures. Further than death, SE can have long-term consequences, including neuronal injury, depending on the type, cause and duration of seizures with severe associated disabilities. In Europe, SE shows an incidence rate ranging about 9 to 40/100,000/y. In adults, mortality of patients with SE is ~30%, and even higher (up to 40%) in refractory status epilepticus. To date, etiology, duration, presence of comorbidity, level of consciousness, semiology and age are the main clinical predictors of SE outcome.

Indexed as

classificationetiologyincidencemortalitystatus epilepticus

Identifiers

PMID34234526
PMCPMC8254099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.